|
|
|
|
| Topics |
Last reply time |
Nickname |
Content |
| Zhaoke Ophthalmology Limited |
2022-03-28T16:11 |
財經茄呢啡 |
兆科眼科在乾眼症、近視及老花三大領域，已有產品完成三期臨床研究或在進行三期臨床研究中；研發亦兼顧角膜修復，並由眼表症狀，延伸到眼底如濕性老年黃斑部病變、糖尿病引發眼疾等方面部署。 |
| Zhaoke Ophthalmology Limited |
2022-03-28T16:11 |
財經茄呢啡 |
兆科眼科（6622）今年內有望推出首款針對青光眼藥物，將開始錄得收入。他提到，隨著集團研發多款藥物進入三期臨床研究階段，料今年研發費用會大幅上升，但手上資金足夠應付未來兩至三年臨床研究所需。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window